A New Drug For A Relentless Brain Disease

A New Drug For A Relentless Brain Disease

  • Af
  • Episode
      756
  • Published
      5. okt. 2022
  • Forlag
0 Anmeldelser
0
Episode
756 of 1420
Længde
13M
Sprog
Engelsk
Format
Kategori
Fakta

ALS is a disease that destroys the nerve cells in the brain and spinal cord we need for voluntary movement. There is no cure, but now there is a newly approved medication that may slow down the disease and extend patients' lives. The drug, called Relyvrio, got its start with a couple of college students, some "ice bucket challenge" money, and a new approach to targeting this disease. Neuroscience correspondent Jon Hamilton checks in with host Emily Kwong about why some advisors aren't persuaded the drug works and how you weigh promising but limited evidence against the backdrop of a 100% fatal disease with hardly any other treatment options?

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for A New Drug For A Relentless Brain Disease

Other podcasts you might like ...